Efavirenz/emtricitabine/tenofovir

(Difference between revisions)

Revision as of 13:29, 16 April 2023

@@ Line 1: / Line 1: @@
 <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/960003/Cv/1'>
-This is a default text for your page '''Efavirenz/emtricitabine/tenofovir'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
+Efavirenz/emtricitabine/tenofovir, sold under the brand name Atripla among others, is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. It contains [[efavirenz]], [[emtricitabine]], and [[tenofovir disoproxil]]. It can be used by itself or together with other antiretroviral medications.
-You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
-== Function ==
-== Disease ==
-== Relevance ==
-== Structural highlights ==
-This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
 </StructureSection>
 == References ==
 <references/>